| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51df6fc8e16dcb4e4f6d9a181c030125 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56938
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
| filingDate |
2014-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebe950057f01455a9c5bb91caa3d312c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_861751bd9478732634923029bf2bd4a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_968f52444f06b65dccb3c8fecd1ba869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54c6779edfd225fd3671125fe2ba80f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e564aa076bafb675fdbc668c9dd8636
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43afbd856d63f6af1049fc95b368a849
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7130f0db77e12a01bee3677b5d2ad31e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7aabed7f7962772260acabfd130c462
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_450c5421ff3fe420b1d22e79297ea313 |
| publicationDate |
2016-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3004884-A1 |
| titleOfInvention |
Diagnosis and/or treatment of diseases, which are related to allergic reactions to staphylococcus aureus |
| abstract |
The invention suggests methods of diagnosis and therapy of diseases, which are related to allergic reactions to the Staphylococcus aureus and corresponding preparations. For diagnosis an interaction of at least one serine protease like protein of Staphylococcus aureus or a derived protein or peptide with a blood sample or a serum sample or a plasma sample of a patient is analyzed. For the therapeutic aspect at least one serine protease like protein of Staphylococcus aureus or a derived protein or peptide is used as allergen in a systemic immune therapy approach. |
| priorityDate |
2013-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |